Matches in Nanopublications for { ?s ?p "[In summary, although heterozygous loss-of- function mutations in AKT2 can cause a syndrome of severe insulin resistance and lipodystrophy in humans, such mutations are uncommon causes of these syndromes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[In summary, although heterozygous loss-of- function mutations in AKT2 can cause a syndrome of severe insulin resistance and lipodystrophy in humans, such mutations are uncommon causes of these syndromes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP172515.RAwGOVZ5d9EWRdAcZSA323EOoymPSlO7pPM7rdtcGxHik130_assertion description "[In summary, although heterozygous loss-of- function mutations in AKT2 can cause a syndrome of severe insulin resistance and lipodystrophy in humans, such mutations are uncommon causes of these syndromes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP172515.RAwGOVZ5d9EWRdAcZSA323EOoymPSlO7pPM7rdtcGxHik130_provenance.
- NP596248.RAWKhIHejlnUSgeiJxMwmcIKFP2sR6Ba0RDzRaTIixGWQ130_assertion description "[In summary, although heterozygous loss-of- function mutations in AKT2 can cause a syndrome of severe insulin resistance and lipodystrophy in humans, such mutations are uncommon causes of these syndromes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP596248.RAWKhIHejlnUSgeiJxMwmcIKFP2sR6Ba0RDzRaTIixGWQ130_provenance.
- NP232977.RAygcanbs5iKuibI0CFYlgE6I2tqudaBOJg-xLJ0BQzO8130_assertion description "[In summary, although heterozygous loss-of- function mutations in AKT2 can cause a syndrome of severe insulin resistance and lipodystrophy in humans, such mutations are uncommon causes of these syndromes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232977.RAygcanbs5iKuibI0CFYlgE6I2tqudaBOJg-xLJ0BQzO8130_provenance.